MedPath

A Randomised control trial comparing the efficacy of two drugs namely Carbetocin and Oxytocin in the active management of third stage of labour

Not Applicable
Not yet recruiting
Conditions
Health Condition 1: O80- Encounter for full-term uncomplicated delivery
Registration Number
CTRI/2022/09/045254
Lead Sponsor
RAJAGIRI HOSPITA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ALL WOMEN UNDERGOING VAGINAL DELIVERIES INCLUDING INSTRUMENTAL DELIVERIES AT RAJAGIRI HOSPITAL DURING THE STUDY PERIOD

Exclusion Criteria

HEPATIC OR RENAL DISEASES

SERIOUS CARDIOVASCULAR DISEASES

EPILEPSY

BLEEDING DIATHESIS

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Compare the mean blood loss ,frequency of cases with blood loss more than 500 ml, drop in Hemoglobin, number of cases requiring additional uterotonic agents has to be used, the occurence of postpartum hemorrhage in both groups, the requirement of blood transfusion between the Carbetocin and Oxytocin groupsTimepoint: 4 Weeks
Secondary Outcome Measures
NameTimeMethod
�To compare the side effect profile of both the drugs including nausea, vomiting, hypotension, dizziness and manual removal of the placentaTimepoint: 4 WEEKS
© Copyright 2025. All Rights Reserved by MedPath